Nautilus Biotechnology Stock (NASDAQ: NAUT)

Nautilus Biotechnology

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

MPLN

NAUT

NKLA

SHCO

U.S. stocks traded lower, with the Dow Jones falling around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Williams-Sonoma, ESS Tech And Other Big Stocks Moving Higher On Monday

BENF

FFIE

FTCH

GNLX

JFIN

PHVS

TLSI

VNET

U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stocks recording gains in today’s session.

Farfetch, Faraday Future Intelligent Electric, VinFast And Other Stocks Moving Lower On Friday

Earnings

Eurozone

Commodities

Global

U.S. stocks traded down this morning with the Nasdaq Composite falling more than 101 points on Friday.

The Dow traded down 0.23% to 34,396.96 while the NASDAQ fell 0.91% to 13,196.22. The S&amp;P 500 also fell, dropping 0.45% to 4,350.51.

US Stocks Sink; Deere Shares Fall Despite Earnings Beat

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology Inc

NAUTILUS MINERALS INC ORD by Nautilus Minerals Inc.

Nauticus Robotics Inc

Press Releases

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Management

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

Health Care

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Akoya Biosciences

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Atlantic International Corp. - Common Stock

Atlantic International

Bionano Genomics

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals

ChromaDex

Codexis

Champions Oncology

CryoPort

Harvard Bioscience

Standard BioTools

Lifecore Biomedical

MaxCyte

Inotiv

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Goldman Sachs

Guggenheim

Jefferies

Morgan Stanley

Comments

Nautilus Biotechnology

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga